Interlink Electronics Inc. showed improvement in the second quarter on both earnings and revenue.

The Westlake Village manufacturer reported on Monday net income of $749,000 (10 cents a share) for the quarter ending June 30, compared with net income of $481,000 (6 cents) in the same period a year earlier. Revenue increased 7 percent to $3.1 million.

No analysts follow the company.

Interlink makes touchpads and computer mouse products for rugged environments such as oil refineries, automobile assembly lines and machine shops. It also serves the medical device market.

Shares closed up 14 cents, or 1.3 percent, to $10.95 on the Nasdaq.


Apollo Medical Holdings Inc. substantially narrowed its losses during the second quarter, the company announced Monday.

The Glendale doctors group and medical provider reported a net loss of $1.3 million (-22 cents a share) for the quarter ended June 30, compared to a loss of $2.5 million (-51 cents) for the same quarter a year ago. Revenue increased 21 percent to $12.4 million.

No analysts follow the company.

Shares closed unchanged at $4.78 on the over-the-counter market.


A pattern of consumers buying lower-cost tickets for shows in Las Vegas affected Tix Corp. revenue in the second quarter.

The Studio City discount ticket broker for shows and attractions in Las Vegas reported Monday net income of $530,000 (3 cents a share) for the quarter ending June 30, compared with net income of $1.6 million (9 cents) in the same period a year earlier. Revenue decreased 10 percent to $5.3 million.

No analysts follow the company.

Chief Executive Mitch Francis attributed the drop in revenue to the closure in April of a Cirque de Soleil show that had provided significant sales last year.

“We also experienced recent trends in consumers purchasing lower-priced show and attraction tickets, which generate lower commissions and fees,” Francis said in a prepared statement. “Also of note is that producers are reporting that ticket sales are generally lower this year versus last year.”

Shares closed down 30 cents, or 13.7 percent, to $1.90 on the over-the-counter market.